Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling

Overview of attention for article published in Frontiers in Molecular Biosciences, September 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 9,215 followers.

RT @MayoClinicNeph: Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling #MayoClinicKidney ht…

RT @MayoClinicNeph: Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling #MayoClinicKidney ht…

RT @MayoClinicNeph: Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling #MayoClinicKidney ht…

New Research: Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling https://t.co/K863Sm3OqS #MolBioSci

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.